He Ziyang, Li Fangyi, Zhang Xinyi, Gao Dacheng, Zhang Zhiwen, Xu Rui, Cao Xingguo, Shan Qiyuan, Ren Zhen, Liu Yali, Xu Zengguang
Research Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Shanghai East Hospital, Postgraduate Training Base of Jinzhou Medical University, Shanghai, China.
Front Pharmacol. 2024 Feb 9;15:1346383. doi: 10.3389/fphar.2024.1346383. eCollection 2024.
Non-small cell lung cancer (NSCLC) is the most common type of lung tumor; however, we lack effective early detection indicators and therapeutic targets. Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) is vital to initiate protein synthesis, acting as a scaffolding protein for the eukaryotic protein translation initiation factor complex, EIF4F, which regulates protein synthesis together with EIF4A, EIF4E, and other translation initiation factors. However, EIF4G1's function in NSCLC cancer is unclear. Herein, transcriptome sequencing showed that knockdown of in H1299 NSCLC cells upregulated the expression of various inflammation-related factors. Inflammatory cytokines were also significantly overexpressed in NSCLC tumor tissues, among which (encoding C-X-C motif chemokine ligand 8) showed the most significant changes in both in the transcriptome sequencing data and tumor tissues. We revealed that EIF4G1 regulates the protein level of TNF receptor superfamily member 10a (TNFRSF10A) resulting in activation of the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NFκB) pathways, which induces CXCL8 secretion, leading to targeted chemotaxis of immune cells. We verified that H1299 cells with knockdown showed increased chemotaxis compared with the control group and promoted increased chemotaxis of macrophages. These data suggested that EIF4G1 is an important molecule in the inflammatory response of cancer tissues in NSCLC.
非小细胞肺癌(NSCLC)是最常见的肺部肿瘤类型;然而,我们缺乏有效的早期检测指标和治疗靶点。真核翻译起始因子4γ1(EIF4G1)对启动蛋白质合成至关重要,它作为真核蛋白质翻译起始因子复合物EIF4F的支架蛋白,与EIF4A、EIF4E和其他翻译起始因子共同调节蛋白质合成。然而,EIF4G1在NSCLC中的功能尚不清楚。在此,转录组测序显示,在H1299 NSCLC细胞中敲低EIF4G1可上调多种炎症相关因子的表达。炎症细胞因子在NSCLC肿瘤组织中也显著过表达,其中(编码C-X-C基序趋化因子配体8)在转录组测序数据和肿瘤组织中均显示出最显著的变化。我们发现EIF4G1调节肿瘤坏死因子受体超家族成员10a(TNFRSF10A)的蛋白水平,导致丝裂原活化蛋白激酶(MAPK)和核因子κB(NFκB)信号通路激活,进而诱导CXCL8分泌,导致免疫细胞的靶向趋化。我们证实,与对照组相比,敲低EIF4G1的H1299细胞趋化性增加,并促进巨噬细胞趋化性增强。这些数据表明,EIF4G1是NSCLC癌组织炎症反应中的一个重要分子。